-
NMPA Announcement on the Release of Revised Draft of the Appendix (Biological Products) as Recorded in the Good Manufacturing Practice for Drugs (Revised in 2010)
2020-04-26
NMPA has,in the light of Article 310 of the Good Manufacturing Practice for Drugs (Revised in 2010), revised the Appendix (Biological Products) (as a supporting document for the GMP), which has been released on April 26, 2020, and will come into force on July 1, 2020.
-
NMPA and NHC Issued Regulations for Administration of Medical Device Extended Clinical Trials (Interim)
2020-03-20
NMPA has, in conjunction with NHC formulated and released on March 20, 2020 the Regulations for Administration of Medical Device Extended Clinical Trials (Interim).
-
NMPA Issued the Notice on Strengthening the Supervision and Inspection of Sterile and Implantable Medical Devices
2020-04-14
On April 14, 2020, NMPA issued the Notice on Strengthening the Supervision and Inspection of Sterile and Implantable Medical Devices.
-
NMPA Issued the Announcement on the Guidance for Medical Device Registrants to Conduct Adverse Events Monitoring
2020-04-10
NMPA has organized the formulation of and released on April 10, 2020 the Guidance for Medical Device Registrants to Conduct Adverse Events Monitoring.
-
NMPA Issued the Announcement on Issues Pertaining to the Current Administration on Drug Distribution
2020-04-03
On April 3, 2020, NMPA issued the Announcement on Issues Pertaining to the Current Administration on Drug Distribution.
-
NMPA Issued the Announcement on Issues Pertaining to the Implementation of the Newly Revised Provisions for the Supervision and Administration of Drug Production
2020-03-31
On March 31, 2020, NMPA issued the Announcement on Issues Pertaining to the Implementation of the Newly Revised Provisions for the Supervision and Administration of Drug Production (No. 47 of 2020).